The global demand for Opioid Induced Constipation (OIC) Drugs Market is presumed to reach the market size of nearly USD XX MN by 2030 from USD XX MN in 2022 with a CAGR of 5.9% under the study period 2023 - 2030.
Opioid Induced Constipation (OIC) Drugs are medications specifically designed to treat constipation that occurs as a side effect of taking opioid medications. Opioids are potent pain-relieving drugs commonly prescribed to manage severe pain, but they can also have unwanted side effects on the digestive system, including constipation. Opioids bind to specific brain and spinal cord receptors, blocking pain signals. Additionally, they have an impact on other body parts, notably the gastrointestinal (GI) tract, as they bind to its receptors and cause a decrease in intestinal movement, resulting in constipation.
The increasing use of opioid medications for pain management, especially in chronic pain conditions, has led to a higher prevalence of opioid-induced constipation, creating a demand for OIC drugs to manage this side effect. The rising awareness in both healthcare professionals and patients about opioid induced constipation has improved diagnosis and treatment, leading to its greater demand. The focus on enhancing the quality of life for the patients has encouraged the search for effective solutions like OIC drugs to alleviate discomfort and improve the overall experience while using opioids for pain management. The prevalence of chronic pain conditions has also contributed to increased opioid use and, consequently, the demand for OIC drugs. Regulatory support and approval have facilitated the accessibility of these drugs in the market, driving competition and innovation. Advancements in opioid induced constipation drug development, the shift towards personalized medicine, and growing healthcare expenditure have further encouraged investment in pharmaceuticals addressing opioid-induced constipation.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of opioid induced constipation (oic) drugs. The growth and trends of opioid induced constipation (oic) drugs industry provide a holistic approach to this study.
This section of the opioid induced constipation (oic) drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Drug Type
By Prescription Type
By Distribution Channel
This section covers the regional outlook, which accentuates current and future demand for the Opioid Induced Constipation (OIC) Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Opioid Induced Constipation (OIC) Drugs market include cosmo pharmaceuticals, Teva Pharmaceutical Industries Ltd., Mallinckrodt plc, Dr. Reddy’s Laboratories Ltd., Novartis AG, Takeda Pharmaceutical Company Limited, Bausch Health Companies Inc., Shionogi & Co. Ltd., Merck & Co. Inc., AstraZeneca plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . OPIOID INDUCED CONSTIPATION (OIC) DRUGS – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Drug Class
3.7.2 Market Attractiveness Analysis By Prescription Type
3.7.3 Market Attractiveness Analysis By Distribution Channel
3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL OPIOID INDUCED CONSTIPATION (OIC) DRUGS MARKET ANALYSIS BY DRUG CLASS
5.1 Overview by Drug Class
5.2 Historical and Forecast Data
5.3 Analysis by Drug Class
5.4 Mu-opioid Receptor Antagonists Historic and Forecast Sales by Regions
5.5 Chloride Channel-2 Activators Historic and Forecast Sales by Regions
5.6 Others Historic and Forecast Sales by Regions
6 . GLOBAL OPIOID INDUCED CONSTIPATION (OIC) DRUGS MARKET ANALYSIS BY PRESCRIPTION TYPE
6.1 Overview by Prescription Type
6.2 Historical and Forecast Data
6.3 Analysis by Prescription Type
6.4 Over The Counter Drugs Historic and Forecast S ...